CYCN
Cyclerion Therapeutics Inc
NASDAQ: CYCN · HEALTHCARE · BIOTECHNOLOGY
$3.31
-0.30% today
Updated 2026-04-30
Market cap
$12.73M
P/E ratio
—
P/S ratio
6.14x
EPS (TTM)
$-1.11
Dividend yield
—
52W range
$1 – $8
Volume
5.6M
Cyclerion Therapeutics Inc (CYCN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
+50.0%
Last 4 quarters
Revenue YoY growth
-43.2%
Most recent quarter
EPS YoY growth
-191.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+1.5%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+13.6%
2025-12-31
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.19 | +50.0% | $1.18 | $1.34 | +13.6% |
| 2025-11-12 | $-0.30 | — | $1.61 | $1.44 | -10.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.38 | $-0.19 | +50.0% | $1.02M | -43.2% |
| 2025-09-30 | $0.00 | $-0.30 | — | $875000.00 | +351.0% |
| 2025-06-30 | — | $-0.11 | — | $93000.00 | — |
| 2025-03-31 | — | $-0.56 | — | $81000.00 | — |
| 2024-12-31 | — | $0.21 | — | $1.81M | — |
| 2024-09-30 | — | $-0.29 | — | $194000.00 | — |
| 2024-06-30 | — | $-0.53 | — | — | — |
| 2024-03-31 | — | $-0.62 | — | — | — |
| 2023-12-31 | — | $-0.68 | — | — | — |
| 2023-09-30 | — | $3.11 | — | — | — |
| 2023-06-30 | $-0.28 | $-1.83 | -554.4% | — | — |
| 2023-03-31 | $-0.30 | $-3.20 | -965.2% | — | — |
Frequently asked questions
Has Cyclerion Therapeutics Inc beaten earnings estimates?
Cyclerion Therapeutics Inc has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of +50.0% over the last 1 quarters.
How does CYCN stock react to earnings?
CYCN stock has moved an average of +1.5% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Cyclerion Therapeutics Inc's revenue growth rate?
Cyclerion Therapeutics Inc reported year-over-year revenue growth of -43.2% in its most recent quarter, with EPS growing -191.3% year-over-year.